tiprankstipranks
10X Genomics (TXG)
:TXG
US Market

10x Genomics (TXG) Income Statement

Compare
1,023 Followers

10x Genomics Income Statement

Last quarter (Q3 2024), 10x Genomics's total revenue was $151.65M, a decrease of -1.30% from the same quarter last year. In Q3, 10x Genomics's net income was $-35.75M. See 10x Genomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 610.78M$ 618.73M$ 516.41M$ 490.49M$ 298.85M
Gross Profit
$ 414.48M$ 409.31M$ 396.02M$ 416.40M$ 240.38M
Operating Expenses
$ 609.04M$ 674.95M$ 563.97M$ 469.31M$ 325.70M
Depreciation and Amortization
$ 0.00$ 43.62M$ 33.01M$ 28.25M$ 19.02M
EBITDA
$ -194.56M$ -205.11M$ -128.49M$ -24.59M$ -513.77M
Operating Income
$ -194.56M$ -194.95M$ -167.94M$ -52.91M$ -85.32M
Other Income/Expenses
$ 16.86M$ -53.81M$ 5.97M$ -802.00K$ -449.15M
Pretax Income
$ -177.70M$ -248.76M$ -161.97M$ -53.72M$ -534.48M
Net Income
$ -182.63M$ -255.10M$ -166.00M$ -58.22M$ -542.73M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.52$ -2.18$ -1.46$ -0.53$ -5.37
Diluted EPS
$ -1.52$ -2.18$ -1.46$ -0.53$ -5.37
Weighted Average Shares Outstanding
120.45M 117.17M 113.86M 110.35M 101.15M
Weighted Average Shares Outstanding (Diluted)
120.45M 117.17M 113.86M 110.35M 101.15M
Currency in USD

10x Genomics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis